Re: Marching on to March events

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Marching on to March events

in response to

Marching on to March events

BearDownAZ

posted on Mar 12, 2018 12:15PM

Zenith BIO-Europe presentation is at 4:15 PM Amsterdam time tomorrow (Tuesday 3/13), which is less than 24 hours from now (10:15 AM Central time here North America). Also, Resverlogix presents 10:45 AM Amsterdam time on Wednesday 3/14, which is pre-market open (4:45 AM Central time). Hopefully both companies issue press releases, or at the very least posts the slide deck on their day of presentation. Sure would be nice to get some good news. GLTA.